Clinical Significance of PCSK9 Therapeutics The PCSK9 Market has become a critical segment within cardiovascular care, targeting elevated LDL-cholesterol levels that persist despite conventional therapies. PCSK9 inhibitors act by preventing the degradation of LDL receptors on hepatocytes, enhancing receptor recycling, and promoting LDL clearance. These therapies provide meaningful LDL...